Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment.
cellular plasticity
malignant melanoma
metabolic reprogramming
molecular classifications
mutational burden
phenotype switching
treatment resistance
tumor microenvironment
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Sep 2023
21 Sep 2023
Historique:
received:
29
08
2023
revised:
17
09
2023
accepted:
20
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Malignant melanoma is a very aggressive skin cancer, characterized by a heterogeneous nature and high metastatic potential. The incidence of melanoma is continuously increasing worldwide, and it is one of the most common cancers in young adults. In the past twenty years, our understanding of melanoma biology has increased profoundly, and disease management for patients with disseminated disease has improved due to the emergence of immunotherapy and targeted therapy. However, a significant fraction of patients relapse or do not respond adequately to treatment. This can partly be explained by the complex signaling between the tumor and its microenvironment, giving rise to melanoma phenotypes with different patterns of disease progression. This review focuses on the key aspects and complex relationship between pathogenesis, genetic abnormalities, tumor microenvironment, cellular plasticity, and metabolic reprogramming in melanoma. By acquiring a deeper understanding of the multifaceted features of melanomagenesis, we can reach a point of more individualized and patient-centered disease management and reduced costs of ineffective treatments.
Identifiants
pubmed: 37762707
pii: ijms241814403
doi: 10.3390/ijms241814403
pmc: PMC10531837
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Kamprad Family Foundation
Références
Int J Mol Sci. 2018 May 24;19(6):
pubmed: 29795011
N Engl J Med. 2006 Jul 6;355(1):51-65
pubmed: 16822996
Oncol Rep. 2016 May;35(5):2499-515
pubmed: 26986034
Int J Mol Sci. 2023 Jun 10;24(12):
pubmed: 37373134
N Engl J Med. 2022 Jan 6;386(1):24-34
pubmed: 34986285
Eur J Cancer. 2022 Jul;170:236-255
pubmed: 35570085
Cancer Res. 2008 Oct 1;68(19):7872-81
pubmed: 18829543
Cancers (Basel). 2022 Jul 28;14(15):
pubmed: 35954345
Nature. 2017 Mar 9;543(7644):252-256
pubmed: 28219080
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Front Immunol. 2023 Aug 25;14:1231734
pubmed: 37691949
JCI Insight. 2022 Oct 10;7(19):
pubmed: 36040798
J Am Acad Dermatol. 2016 Mar;74(3):395-407; quiz 408-10
pubmed: 26892650
Br J Cancer. 2016 Aug 9;115(4):454-64
pubmed: 27441500
Front Mol Biosci. 2022 May 19;9:810858
pubmed: 35664673
Cancer Commun (Lond). 2020 Apr;40(4):135-153
pubmed: 32301585
Front Oncol. 2021 Jul 14;11:668349
pubmed: 34336660
Front Oncol. 2022 Nov 17;12:1089265
pubmed: 36465347
J Immunother Cancer. 2019 Nov 15;7(1):308
pubmed: 31730502
J Clin Aesthet Dermatol. 2014 Jun;7(6):13-24
pubmed: 25013535
Front Oncol. 2021 Sep 16;11:756001
pubmed: 34604096
Pathology. 2016 Feb;48(2):177-87
pubmed: 27020390
Front Oncol. 2015 Feb 13;5:31
pubmed: 25763355
Nat Rev Mol Cell Biol. 2007 Oct;8(10):786-97
pubmed: 17878918
Br J Cancer. 2017 Nov 21;117(11):1583-1591
pubmed: 29065107
Genes Dev. 2012 May 15;26(10):1055-69
pubmed: 22549727
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Rev Cancer. 2019 Jul;19(7):377-391
pubmed: 31209265
Nat Commun. 2017 Oct 26;8(1):1136
pubmed: 29070816
Cancer Manag Res. 2018 May 14;10:1143-1154
pubmed: 29795986
Nat Commun. 2020 Apr 20;11(1):1897
pubmed: 32312968
Cancer Lett. 2022 Dec 1;550:215925
pubmed: 36183857
Science. 2013 Feb 22;339(6122):959-61
pubmed: 23348503
Semin Cancer Biol. 2019 Dec;59:236-250
pubmed: 31404607
Nature. 2005 Aug 4;436(7051):720-4
pubmed: 16079850
J Clin Med. 2020 Jan 23;9(2):
pubmed: 31979325
Ann N Y Acad Sci. 1991;615:158-71
pubmed: 2039141
Nature. 2020 Jan;577(7791):549-555
pubmed: 31942075
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Acta Derm Venereol. 2020 Jun 3;100(11):adv00141
pubmed: 32346745
Oncotarget. 2019 Jan 29;10(9):922-923
pubmed: 30847019
Hum Mol Genet. 2014 Nov 15;23(22):6112-8
pubmed: 24943595
Pigment Cell Res. 2006 Aug;19(4):290-302
pubmed: 16827748
J Hematol Oncol. 2021 Jun 25;14(1):98
pubmed: 34172088
Cell. 2018 Nov 1;175(4):984-997.e24
pubmed: 30388455
Semin Cancer Biol. 2019 Dec;59:290-297
pubmed: 31430555
Nat Methods. 2014 Apr;11(4):417-22
pubmed: 24584193
Nat Rev Cancer. 2022 Apr;22(4):195-207
pubmed: 35105962
Clin Cancer Res. 2010 Jul 1;16(13):3356-67
pubmed: 20460471
Front Oncol. 2020 May 19;10:851
pubmed: 32509589
Cancer Sci. 2019 Jul;110(7):2080-2089
pubmed: 31102428
Yonsei Med J. 2020 Jul;61(7):562-571
pubmed: 32608199
J Photochem Photobiol B. 1991 May;9(2):135-60
pubmed: 1907647
Nat Med. 2010 Aug;16(8):880-6
pubmed: 20622859
Cancer Discov. 2014 Jul;4(7):816-27
pubmed: 24771846
Nature. 2010 Dec 16;468(7326):973-7
pubmed: 21107323
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):313-322
pubmed: 30776401
Am J Clin Pathol. 2022 May 4;157(5):644-648
pubmed: 34864837
Histopathology. 2018 Aug;73(2):197-206
pubmed: 29457843
Cancers (Basel). 2022 Sep 24;14(19):
pubmed: 36230575
Development. 2015 Apr 1;142(7):1387
pubmed: 25804742
Cancer Treat Rev. 2021 Sep;99:102238
pubmed: 34098219
FEBS J. 2022 Mar;289(5):1352-1368
pubmed: 33999497
Nat Genet. 2000 Feb;24(2):144-52
pubmed: 10655059
Cancer Res. 2012 Mar 1;72(5):1070-80
pubmed: 22266112
Genes Dev. 2007 Nov 15;21(22):2923-35
pubmed: 18006687
Dermatol Res Pract. 2010;2010:
pubmed: 20936153
J Invest Dermatol. 1998 Dec;111(6):936-40
pubmed: 9856799
Lancet. 2021 Sep 11;398(10304):1002-1014
pubmed: 34509219
Signal Transduct Target Ther. 2021 Dec 20;6(1):424
pubmed: 34924562
Cancer Res. 2008 Oct 1;68(19):7788-94
pubmed: 18829533
Acta Pharmacol Sin. 2023 Feb;44(2):288-307
pubmed: 35927312
Melanoma Res. 2022 Dec 1;32(6):405-410
pubmed: 36125897
Cell. 2017 Jan 26;168(3):542
pubmed: 28129544
Int J Oncol. 2018 Apr;52(4):1071-1080
pubmed: 29532857
Cancer Discov. 2013 Dec;3(12):1378-93
pubmed: 24104062
Oncogene. 2007 May 14;26(22):3279-90
pubmed: 17496922
Oncogene. 2011 Jul 7;30(27):3036-48
pubmed: 21358674
Virchows Arch. 2018 Oct;473(4):405-412
pubmed: 30030621
Int J Mol Sci. 2023 Jan 13;24(2):
pubmed: 36675114
Cancer Metastasis Rev. 2023 Feb 24;:
pubmed: 36826760
J Med Genet. 2016 Jan;53(1):1-14
pubmed: 26337759
Commun Biol. 2021 Aug 26;4(1):1011
pubmed: 34446834
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Cell Res. 2018 Mar;28(3):265-280
pubmed: 29219147
Nat Immunol. 2022 Sep;23(9):1309-1316
pubmed: 36002647
Annu Rev Immunol. 2011;29:235-71
pubmed: 21219185
Lab Invest. 2021 Dec;101(12):1561-1570
pubmed: 34446805
Immunity. 1997 Feb;6(2):199-208
pubmed: 9047241
Cancer Gene Ther. 2022 Jun;29(6):647-660
pubmed: 34158626
J Clin Invest. 2013 Feb;123(2):566-79
pubmed: 23321667
Nat Commun. 2014 Dec 15;5:5712
pubmed: 25502142
Cancer Res. 2015 Sep 15;75(18):3747-59
pubmed: 26183926
Exp Ther Med. 2022 Jun;23(6):402
pubmed: 35601077
Clin Rev Allergy Immunol. 2020 Jun;58(3):313-325
pubmed: 31256327
World J Oncol. 2021 Feb;12(1):7-19
pubmed: 33738001
Nat Cell Biol. 2020 Aug;22(8):986-998
pubmed: 32753671
Front Oncol. 2021 Dec 01;11:763992
pubmed: 34926265
Cell. 2016 Dec 1;167(6):1540-1554.e12
pubmed: 27912061
Semin Cancer Biol. 2004 Apr;14(2):105-14
pubmed: 15018894
Anal Cell Pathol (Amst). 2019 Dec 16;2019:3851576
pubmed: 31934531
Nature. 2011 Jun 08;474(7350):171-2
pubmed: 21654798
Cancer Cell. 2018 May 14;33(5):890-904.e5
pubmed: 29657129
Front Oncol. 2015 Oct 20;5:224
pubmed: 26539408
Nature. 2020 Jan;577(7791):561-565
pubmed: 31942071
N Engl J Med. 2022 Dec 8;387(23):2113-2125
pubmed: 36477031
JCI Insight. 2018 Dec 20;3(24):
pubmed: 30568030
Biochim Biophys Acta. 2016 Apr;1863(4):770-84
pubmed: 26844774
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
J Natl Cancer Inst. 2012 Jun 20;104(12):953-6
pubmed: 22534780
Pigment Cell Melanoma Res. 2021 May;34(3):529-549
pubmed: 32939993
Am J Surg Pathol. 2020 Jul;44(7):893-900
pubmed: 32317605
Cancer Res Treat. 2020 Jan;52(1):98-108
pubmed: 31163960
JAMA Dermatol. 2022 May 1;158(5):495-503
pubmed: 35353115
Clin Cancer Res. 2014 Dec 15;20(24):6593-604
pubmed: 25294904
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):556-572
pubmed: 28167100
Front Oncol. 2022 Dec 22;12:1046102
pubmed: 36620597
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
Cell Res. 2008 Dec;18(12):1163-76
pubmed: 19002157
Cell. 2018 Aug 9;174(4):843-855.e19
pubmed: 30017245
Am J Surg Pathol. 2018 Nov;42(11):1456-1465
pubmed: 30045064
Cancers (Basel). 2022 Dec 12;14(24):
pubmed: 36551603
J Invest Dermatol. 2017 Oct;137(10):2197-2207
pubmed: 28647344
Hematol Oncol Clin North Am. 2009 Jun;23(3):501-13, ix
pubmed: 19464599
Nat Commun. 2015 Apr 09;6:6683
pubmed: 25865119
J Biomed Sci. 2022 Nov 14;29(1):96
pubmed: 36376874
Cancer Res. 2004 Aug 1;64(15):5270-82
pubmed: 15289333
Genes (Basel). 2022 Mar 19;13(3):
pubmed: 35328098
Head Neck Pathol. 2023 Mar;17(1):143-153
pubmed: 36928737
Comput Struct Biotechnol J. 2013 Dec 07;6:e201303019
pubmed: 24688727
J Biol Chem. 2017 Jul 14;292(28):11727-11739
pubmed: 28546431
Expert Rev Anticancer Ther. 2018 Aug;18(8):775-784
pubmed: 29923435
Clin Cancer Res. 2012 Aug 1;18(15):4026-36
pubmed: 22675174
Cancers (Basel). 2022 Aug 08;14(15):
pubmed: 35954496
Eur J Pharm Biopharm. 2023 Mar;184:214-247
pubmed: 36773725
Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S17-27
pubmed: 22443084
Cureus. 2023 May 8;15(5):e38693
pubmed: 37292567
Cancer Lett. 2017 Apr 10;391:125-140
pubmed: 28131904
Nature. 2005 Jul 7;436(7047):117-22
pubmed: 16001072
Pigment Cell Melanoma Res. 2022 Jul;35(4):471-473
pubmed: 35452161
Cancers (Basel). 2021 Apr 26;13(9):
pubmed: 33925915
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Pigment Cell Melanoma Res. 2011 Jun;24(3):525-37
pubmed: 21435193
Biomedicines. 2021 Apr 02;9(4):
pubmed: 33918295
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Cell. 2019 Sep 19;179(1):236-250.e18
pubmed: 31495571
Mol Cell. 2013 Aug 22;51(4):409-22
pubmed: 23973372
Pharmacol Res. 2017 Sep;123:95-102
pubmed: 28690075
Cancer. 2014 Nov 15;120(22):3446-56
pubmed: 24948110
PLoS One. 2021 Feb 17;16(2):e0247238
pubmed: 33596250
Nat Med. 2023 Jan;29(1):104-114
pubmed: 36624315
Genes Dev. 2019 Oct 1;33(19-20):1295-1318
pubmed: 31575676
Eur J Cancer. 2010 May;46(8):1413-20
pubmed: 20189796
Nat Rev Cancer. 2008 Sep;8(9):705-13
pubmed: 19143055
Cell Rep. 2017 Apr 4;19(1):203-217
pubmed: 28380359
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
Pigment Cell Melanoma Res. 2010 Dec;23(6):746-59
pubmed: 20726948
Clin Cancer Res. 2023 Jul 5;29(13):2513-2524
pubmed: 36790412
Eur J Cancer. 2022 Jul;170:256-284
pubmed: 35623961
Medicine (Baltimore). 2016 Jul;95(29):e4332
pubmed: 27442685
Oncotarget. 2014 Apr 15;5(7):1701-52
pubmed: 24743024
Histopathology. 2000 May;36(5):387-402
pubmed: 10792480
Cancer Res. 2008 May 1;68(9):3429-39
pubmed: 18451171
Acta Dermatovenerol Croat. 2014;22(1):1-12
pubmed: 24813835
J Cell Mol Med. 2017 Aug;21(8):1463-1467
pubmed: 28244655
Cancer Gene Ther. 2021 Sep;28(9):984-999
pubmed: 33712707
Nat Genet. 2009 May;41(5):544-52
pubmed: 19282848
Transl Oncol. 2017 Dec;10(6):956-975
pubmed: 29078205